Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.

Nymoen, Dag Andre; Hetland Falkenthal, Thea E; Holth, Arild; Ow, Ghim Siong; Ivshina, Anna V; Tropé, Claes G; Kuznetsov, Vladimir A; Staff, Anne Cathrine; Davidson, Ben

Nymoen, Dag Andre; Hetland Falkenthal, Thea E; Holth, Arild; Ow, Ghim Siong; Ivshina, Anna V; Tropé, Claes G; Kuznetsov, Vladimir A; Staff, Anne Cathrine; Davidson, Ben.

Afiliação

Nymoen DA; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway.
Hetland Falkenthal TE; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway.
Holth A; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway.
Ow GS; Bioinformatics Institute, A*STAR, Singapore.
Ivshina AV; Bioinformatics Institute, A*STAR, Singapore.
Tropé CG; Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway; University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, N-0310 Oslo, Norway.
Kuznetsov VA; Bioinformatics Institute, A*STAR, Singapore; School for Integrative Science and Engineering, National University of Singapore, Singapore; School of Computing Engineering, Nanyang Technological University, Singapore.
Staff AC; University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, N-0310 Oslo, Norway; Department of Obstetrics and Gynecology, Ulleval University Hospital, N-0407 Oslo, Norway.
Davidson B; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway; University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, N-0310 Oslo, Norway. Electronic address: bend@medisin.uio.no.

Gynecol Oncol ; 139(1): 30-9, 2015 Oct.

Article em En | MEDLINE | ID: mdl-26232338

Assuntos

Biomarcadores Tumorais/genética; Cistadenocarcinoma Seroso/tratamento farmacológico; Cistadenocarcinoma Seroso/genética; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/genética; Proteínas Adaptadoras de Transdução de Sinal/biossíntese; Proteínas Adaptadoras de Transdução de Sinal/genética; Proteína da Polipose Adenomatosa do Colo/biossíntese; Proteína da Polipose Adenomatosa do Colo/genética; Adulto; Idoso; Idoso de 80 Anos ou mais; Anexina A2/biossíntese; Anexina A2/genética; Proteínas Reguladoras de Apoptose/biossíntese; Proteínas Reguladoras de Apoptose/genética; Biomarcadores Tumorais/biossíntese; Cistadenocarcinoma Seroso/metabolismo; Resistencia a Medicamentos Antineoplásicos/genética; Feminino; Expressão Gênica; Humanos; Pessoa de Meia-Idade; Proteína Quinase 3 Ativada por Mitógeno/biossíntese; Proteína Quinase 3 Ativada por Mitógeno/genética; Neoplasias Ovarianas/metabolismo; Prognóstico; RNA Mensageiro/genética; RNA Mensageiro/metabolismo; Proteínas S100/biossíntese; Proteínas S100/genética

Palavras-chave

Chemotherapy response; Metastases; Ovarian serous carcinoma; Quantitative PCR; Survival; Tumor heterogeneity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Cistadenocarcinoma Seroso Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google